3-Methyl-7-[2-methyl-3-(1-phenyltetrazol-5-yl)sulfanylpropyl]-8-(4-methylpiperidin-1-yl)-4,5-dihydropurine-2,6-dione
3-甲基-7-[2-甲基-3-(1-苯基四唑-5-基)硫代丙基]-8-(4-甲基哌啶-1-基)-4,5-二氢嘌呤-2,6-二酮
3-Methyl-7-[2-methyl-3-(1-phenyltetrazol-5-yl)sulfanylpropyl]-8-(4-methylpiperidin-1-yl)-4,5-dihydropurine-2,6-dione (CAS 714225-43-1) is a compound in the Pharma Intermediates category listed in the Jingsj chemical database. It has the molecular formula C23H31N9O2S and a molecular weight of 497.6 g/mol. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.
- CAS No.
- 714225-43-1
- Jingsj CID
- J-203361-5
- Molecular Formula
- C23H31N9O2S
- Chinese Name
- 3-甲基-7-[2-甲基-3-(1-苯基四唑-5-基)硫代丙基]-8-(4-甲基哌啶-1-基)-4,5-二氢嘌呤-2,6-二酮
- Molecular Weight
- 497.6 g/mol
- Category
- Pharma Intermediates
- Last updated
- 8/21/2026
No offers for this compound yet.
Request a quoteFrequently Asked Questions
What is the CAS number of 3-Methyl-7-[2-methyl-3-(1-phenyltetrazol-5-yl)sulfanylpropyl]-8-(4-methylpiperidin-1-yl)-4,5-dihydropurine-2,6-dione?
The CAS number of 3-Methyl-7-[2-methyl-3-(1-phenyltetrazol-5-yl)sulfanylpropyl]-8-(4-methylpiperidin-1-yl)-4,5-dihydropurine-2,6-dione is 714225-43-1.
What are the molecular formula and molecular weight of 3-Methyl-7-[2-methyl-3-(1-phenyltetrazol-5-yl)sulfanylpropyl]-8-(4-methylpiperidin-1-yl)-4,5-dihydropurine-2,6-dione?
3-Methyl-7-[2-methyl-3-(1-phenyltetrazol-5-yl)sulfanylpropyl]-8-(4-methylpiperidin-1-yl)-4,5-dihydropurine-2,6-dione has molecular formula C23H31N9O2S and molecular weight 497.6 g/mol.
Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.
Last updated:
How to cite: Jingsj. "3-Methyl-7-[2-methyl-3-(1-phenyltetrazol-5-yl)sulfanylpropyl]-8-(4-methylpiperidin-1-yl)-4,5-dihydropurine-2,6-dione (CAS 714225-43-1)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-203361-5 (accessed 2026-10-24).
Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.